Between 2009 and 2013, researchers provided diabetes and hypertension patients with the option to receive e-message reminders about their treatments. The likelihood of patients completing their tests each year increased between 1 percent and 7 percent for patients receiving e-messages during the testing period. The group receiving reminders also experienced small improvement in markers like HbA1c and LDL for those with diabetes.
“Patient-initiated e-messaging may increase the likelihood of completing recommended tests, but may not be sufficient to improve clinical outcomes for most patients with diabetes or hypertension without additional interventions,” the authors concluded.
More articles on health IT:
Cedars-Sinai to use Fitbits for patient tracking in small cancer trial
UPMC-backed health science initiative awards funding to 3 startups
8 CIO concerns for 2016
